Thymosin Alpha-1 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Thymosin Alpha 1 also known as TA1 is a research peptide investigated for its relevance to immune-modulation studies biochemical defence-pathway modelling and controlled evaluation of peptide-receptor interactions. This lyophilized 10 mg preparation supports laboratory analysis of purity identity and mechanistic behaviour.   Peptide Overview Between 2010 and 2025 Thymosin Alpha 1 gained widespread scientific attention due to its involvement in immune-related pathways and its stable analytical performance in in-vitro systems. Its defined biochemical structure supports reproducible research across immunological and regulatory-pathway models.   Historical Background and Scientific Context Scientific interest in TA1 expanded significantly from 2012 onward as research groups evaluated its activity in immune-defence mechanisms and cellular-signalling models. Thymosin Alpha 1 became a reference peptide for in-vitro immune-pathway modelling and comparative biochemical studies.   Mechanistic Focus in Research

• Immune-modulation pathway modelling
• Biochemical defence-mechanism evaluation
• Receptor-interaction and regulatory-pathway studies
• Comparative analysis with immune-related peptides
• Controlled in-vitro structure–function experimentation

  Analytical Verification (COA) Independent Liquilabs analysis confirms full validation for Batch GF082025008. Key results include:

• Assay Content: 10.13 mg
• Identification – Retention Time: 0.992
• Identification – Spectrum: 986
• Purity: above 99.8%
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury and vanadium

All analytical values were obtained using validated chromatographic spectroscopic and microbiological procedures ensuring transparent documentation and full traceability.   Research Applications

• Immune-system signalling and biochemical-pathway modelling
• Regulatory and defence-mechanism evaluation
• Comparative peptide-activity profiling
• Controlled in-vitro immunological modelling
• Structure–function pathway analysis

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Purity above 99.8% with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin level below 0.001 EU per mg
• Batch GF082025008 – Published September 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.